A Multicentre, Randomised, Single-blind, Controlled Protocol to Evaluate the Efficacy of Early Administration of Botulinum Toxin for Primary Midline Closure in Patients With Open Abdomen.

Clinical trial NCT06556030 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06556030
Sponsor: Instituto de Investigación Hospital Universitario La Paz
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Botulinum Toxin Type A Open Abdomen Abdominal Wall Clinical Trial

Start date: 2025-01-01
Primary completion: 2026-06-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.